Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis
(MedPage Today) — In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placebo-controlled TETON-2 trial found. With a year… Source: Read Full Article
